Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Price Passes Below 50-Day Moving Average - Here's What Happened

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF - Get Free Report)'s share price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $10.23 and traded as low as $9.72. Ono Pharmaceutical shares last traded at $9.72, with a volume of 2,331 shares changing hands.

Ono Pharmaceutical Stock Performance

The company has a market cap of $4.65 billion, a P/E ratio of 9.52 and a beta of 0.59. The company's fifty day moving average is $10.19 and its 200 day moving average is $12.23. The company has a current ratio of 3.22, a quick ratio of 2.80 and a debt-to-equity ratio of 0.15.

Ono Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $0.21 earnings per share (EPS) for the quarter. Ono Pharmaceutical had a return on equity of 9.14% and a net margin of 15.15%.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.